1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with nb 598 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (nb 598) | Trials (nb 598) | Recent Studies (post-2010) (nb 598) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 27 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaei, P; MacNulty, EE; Ryder, NS | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and nb 598
| Article | Year |
|---|---|
Inhibition of protein prenylation down-regulates signalling by inflammatory mediators in human keratinocytes.
Topics: Adenosine Triphosphate; Benzylamines; Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Inositol 1,4,5-Trisphosphate; Keratinocytes; Mevalonic Acid; Platelet Activating Factor; Protein Prenylation; Signal Transduction; Thiophenes; Thrombin | 1996 |